Advertisement

France

  • Liliana EskenaziEmail author
  • Olivier Fréget
  • Laetitia Ghebali
  • Clément Hubert
  • Martina Isola
  • Nizar Lajnef
  • Jean-Julien LemonnierEmail author
Chapter
  • 399 Downloads
Part of the LIDC Contributions on Antitrust Law, Intellectual Property and Unfair Competition book series (LIDC)

Abstract

This chapter provides an overview of the competition law implementation in the pharmaceutical sector in France. It outlines some regulatory specificities and reviews recent case law highlighting the French authorities and courts' approach to commercial denigration, interplay between competition and IP rights, online sales of medicinal products.

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  • Liliana Eskenazi
    • 1
    Email author
  • Olivier Fréget
    • 1
  • Laetitia Ghebali
    • 2
  • Clément Hubert
    • 3
  • Martina Isola
    • 4
  • Nizar Lajnef
    • 5
  • Jean-Julien Lemonnier
    • 2
    Email author
  1. 1.FTDP AvocatsParisFrance
  2. 2.White & Case LLPParisFrance
  3. 3.FieldfisherParisFrance
  4. 4.Association Française d’Etude de la concurrence (AFEC)ParisFrance
  5. 5.UGGC AvocatsParisFrance

Personalised recommendations